The FDA has cleared Thermo Fisher Scientific’s test, the first of its kind in the country, to detect women with risk of severe preeclampsia, the company said.
https://www.pharmalive.com/wp-content/uploads/2022/06/ReutersFDA6-10-2022.jpg8001200Reuters Healthhttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngReuters Health2023-05-19 08:50:592023-05-19 08:58:27Thermo Fisher’s test to detect pregnancy-related complication gets FDA nod
